While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats ...

The press release also contained forward-looking statements, cautioning that these are not guarantees and are subject to risks, uncertainties, and other factors that could cause actual results to ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As clinical trials advance, Ben Hargreaves finds the technology is poised to ...

Based on its share price, down 75% in the last three years, it's easy to write off Moderna (NASDAQ: MRNA) as a biotech ...

As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

President Donald Trump announced a $500billion investment for private companies to develop artificial intelligence tools to ...

Polk County’s level of immunization for kindergartners dropped from 96.3% in 2021 to 93.2% in 2023, still above the statewide ...

The support is designed to speed development of well-matched H5N1 vaccines and pave the way for vaccines against other ...

As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural ...

The coronavirus pandemic demands nations to ... While South Africa has developed an mRNA vaccine construct based on publicly available information, this is a new construct and must go through ...